Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of VGF mRNA | increases expression | 19933214
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of VGF mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of VGF mRNA | increases expression | 18687144
|
D002330 |
Carmustine |
Carmustine results in decreased expression of VGF mRNA | decreases expression | 15980968
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of VGF mRNA | affects cotreatment|increases expression | 18606552
|
C056507 |
gemcitabine |
gemcitabine results in decreased expression of VGF mRNA | decreases expression | 17039268
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of VGF mRNA | affects cotreatment|increases expression | 18606552
|
D006851 |
Hydrochloric Acid |
Hydrochloric Acid results in decreased expression of VGF mRNA | decreases expression | 15046208
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of VGF mRNA | increases expression | 17616710
|
D010126 |
Ozone |
Ozone results in decreased expression of VGF mRNA | decreases expression | 16330353
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA | affects cotreatment|increases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of VGF mRNA | increases expression | 19933214
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of VGF mRNA | increases expression | 19101580
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA | affects cotreatment|increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.59 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.59 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.98 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
11.01 | 18287403 |
MESH:D000138 |
Acidosis |
|
Hydrochloric Acid |
11.01 | 11574821 16144966 19262391 15920416 12771618 20872349 |
MESH:D000141 |
Acidosis, Renal Tubular |
|
Hydrochloric Acid |
5.84 | 17183249 |
MESH:D000142 |
Acidosis, Respiratory |
|
Hydrochloric Acid |
5.91 | 20597076 |
MESH:D055371 |
Acute Lung Injury |
|
Hydrochloric Acid |
4.84 | 19060228 19094174 19760209 15970105 11850527 11953099 16759491 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.45 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D000860 |
Anoxia |
|
Hydrochloric Acid |
5.39 | 15090967 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.62 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.57 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.65 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 19232924 15238991 18775368 18316065 18177632 17157402 16609825 20603192 19460635 17507914 18396377 17688650 18940202 18558336 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.10 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Hydrochloric Acid |
9.56 | 15920416 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.56 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.13 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.13 | 8888407 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.44 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
2.37 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.37 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Hydrochloric Acid |
9.08 | 12378975 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
9.08 | 18315731 17626835 18417511 16777450 19059883 15516495 14754758 |
MESH:D001986 |
Bronchial Spasm |
|
Hydrochloric Acid |
5.56 | 15578804 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.82 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.00 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.74 | 10591146 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 16354765 15668235 8697196 15340226 12621046 |
MESH:D003092 |
Colitis |
|
Selenium |
3.85 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.80 | 17688650 16575769 8888407 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.80 | 19769572 |
MESH:D003556 |
Cystitis |
|
Hydrochloric Acid |
5.56 | 12853844 19279288 20719367 12599022 |
MESH:D018856 |
Cystitis, Interstitial |
|
Hydrochloric Acid |
5.91 | 17714534 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.31 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.31 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.31 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.68 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
8.68 | 7515130 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.11 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.80 | 9068938 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.23 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.01 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.96 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.63 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.37 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.15 | 3659116 |
MESH:D004935 |
Esophageal Diseases |
|
Hydrochloric Acid |
5.88 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
2.79 | 16704527 15878914 15264214 15547721 16510608 16805852 15623463 15150132 15547733 |
MESH:D004941 |
Esophagitis |
|
Hydrochloric Acid |
6.08 | 12928072 |
MESH:D004942 |
Esophagitis, Peptic |
|
Hydrochloric Acid |
6.11 | 11346197 20516732 14621274 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.64 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
8.64 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.98 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.19 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Hydrochloric Acid |
9.30 | 18497604 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.30 | 20067830 |
MESH:D005739 |
Gas Poisoning |
|
Hydrochloric Acid |
5.56 | 12378975 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Hydrochloric Acid |
5.39 | 20616304 12212954 20545468 20516732 19957777 19951613 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
3.96 | 16187019 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006356 |
Heartburn |
|
Hydrochloric Acid |
5.88 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.66 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.66 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.11 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 12621046 16120746 15340226 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.72 | 16863852 16490937 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.36 | 17457083 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.07 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 18606429 15340226 16354765 16959395 8697196 |
MESH:D006940 |
Hyperemia |
|
Hydrochloric Acid |
5.73 | 12646421 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Hydrochloric Acid |
5.42 | 16984587 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Hydrochloric Acid |
4.49 | 19262391 |
MESH:D007022 |
Hypotension |
|
Hydrochloric Acid |
4.82 | 11574821 |
MESH:D007249 |
Inflammation |
|
Hydrochloric Acid |
5.44 | 11574821 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.44 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.29 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.29 | 16624496 |
MESH:D007410 |
Intestinal Diseases |
|
Hydrochloric Acid |
5.04 | 11574821 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.83 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.94 | 16518626 |
MESH:D007818 |
Laryngeal Diseases |
|
Hydrochloric Acid |
6.46 | 16498863 |
MESH:D007826 |
Laryngismus |
|
Hydrochloric Acid |
6.46 | 11510729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.16 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Hydrochloric Acid |
4.10 | 16984587 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.35 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.73 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.14 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Hydrochloric Acid |
12.73 | 16784557 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
12.73 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
12.73 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.36 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
15.79 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Hydrochloric Acid |
15.79 | 19644408 18573544 21114838 15044056 18497604 21311175 17627322 11395602 20597076 19262391 16129981 18339021 15090967 15607125 |
MESH:D055370 |
Lung Injury |
|
Ozone |
15.79 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.47 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.47 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.47 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.68 | 9488045 8764131 11980663 8840982 17941976 18798262 9205081 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.79 | 15318939 |
MESH:D008545 |
Melanoma |
|
Carmustine |
2.87 | 12393984 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.40 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.40 | 15107826 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.20 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.23 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.08 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.18 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Hydrochloric Acid |
3.83 | 18534312 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
5.17 | 9205081 9488045 8764131 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.40 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.16 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
Hydrochloric Acid |
4.81 | 12378975 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
3.55 | 18992248 11504793 17440100 18383843 16929163 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
11.15 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
11.15 | 18606552 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.20 | 16369182 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.99 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.96 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.48 | 18007984 18929643 18381685 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Hydrochloric Acid |
5.45 | 18573544 15970105 18497604 15607125 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.74 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.74 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.30 | 15084515 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.64 | 11422049 12752131 |
MESH:D001261 |
Pulmonary Atelectasis |
|
Hydrochloric Acid |
6.11 | 20597076 |
MESH:D011654 |
Pulmonary Edema |
|
Hydrochloric Acid |
5.31 | 15090967 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.05 | 17975199 15814490 17322281 17365031 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Hydrochloric Acid |
4.82 | 16784557 17627322 18549715 16129981 18339021 |
MESH:D012133 |
Respiratory Paralysis |
|
Hydrochloric Acid |
6.46 | 11510729 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Hydrochloric Acid |
5.26 | 20516732 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.23 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.77 | 11044598 16876388 3137016 14763951 15475178 1511512 11738929 17978042 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.45 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.82 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.64 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
2.32 | 17575124 12958204 |
MESH:D013276 |
Stomach Ulcer |
|
Hydrochloric Acid |
4.28 | 16755016 15309881 17189318 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.56 | 16517955 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.33 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.60 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.71 | 8888407 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |